Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
161.3 USD | -0.78% | +1.99% | +10.07% |
Apr. 26 | Colgate-Palmolive raises sales growth target after strong Q1 results | RE |
Apr. 25 | Argus Adjusts Procter & Gamble's Price Target to $185 From $180, Keeps Buy Rating | MT |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The opinion of analysts covering the stock has improved over the past four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company benefits from high valuations in earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+10.07% | 381B | C- | ||
+14.18% | 74.67B | A+ | ||
-16.59% | 62.59B | A- | ||
+0.82% | 52.86B | B+ | ||
-12.40% | 36.11B | - | ||
+3.54% | 33.57B | B- | ||
+7.92% | 17.29B | A- | ||
+6.30% | 14.75B | B | ||
-8.65% | 10.82B | C+ | ||
+12.89% | 9.31B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- PG Stock
- Ratings Procter & Gamble Company